Intravascular volume expansion: which surrogate markers could help the clinician to assess improved tissue perfusion?
Benoit
B
Vallet
D000818:Animals; D015415:Biomarkers; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage; D010100:Oxygen / Q000097:blood; D010952:Plasma Substitutes / Q000008:administration & dosage; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage; D012771:Shock, Hemorrhagic / Q000097:blood / Q000503:physiopathology* / Q000628:therapy; D013152:Splanchnic Circulation / Q000187:drug effects; D013270:Stomach / Q000098:blood supply; D013997:Time Factors; D016896:Treatment Outcome
D015415:Biomarkers; D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes; D012462:Saline Solution, Hypertonic; D002245:Carbon Dioxide; D010100:Oxygen